Cargando…

Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments

Some infection control recommendations distinguish epidemic and endemic levels for infection control. However, it is often difficult to separate long lasting outbreaks from high endemic levels and it remains open, if this distinction is really useful. Aim: To compare infection control measures in en...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulrich, Nikos, Gastmeier, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574254/
https://www.ncbi.nlm.nih.gov/pubmed/28890862
http://dx.doi.org/10.3205/dgkh000299
_version_ 1783259795663355904
author Ulrich, Nikos
Gastmeier, Petra
author_facet Ulrich, Nikos
Gastmeier, Petra
author_sort Ulrich, Nikos
collection PubMed
description Some infection control recommendations distinguish epidemic and endemic levels for infection control. However, it is often difficult to separate long lasting outbreaks from high endemic levels and it remains open, if this distinction is really useful. Aim: To compare infection control measures in endemic and epidemic outbreaks. Methods: The example of vancomycin-resistant Enterococcus faecium outbreaks in haematology or oncology departments was used to analyse differences in infection control measures between outbreaks and high endemic levels. The outbreak database and PubMed, including long lasting outbreaks, were used for this analysis. Two time limits were used for separation: 6 and 12 months. In addition, monoclonal and polyclonal outbreaks were distinguished. Findings: A total of 36 outbreaks were included. 13 outbreaks lasted 6 months or less, 9 outbreaks more than 6 months but at maximum 12 months and 9 more than 12 months. For the remaining outbreaks, no information about their duration was available. Altogether, 11 outbreaks were monoclonal and 20 polyclonal. Considering infection control measures, there were almost no differences between the different groups compared. Patient screening was given up in 37.5% of long lasting outbreaks (>12 months) and hand hygiene not reported in the majority of polyclonal outbreaks (77.8%). Conclusion: Despite many institutions trying to add further infection control measures in case of an outbreak, evidence based infection control measures should be implemented in endemic and epidemic situations. The crucial aspect is probably the degree of implementation and its control in both situations.
format Online
Article
Text
id pubmed-5574254
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher German Medical Science GMS Publishing House
record_format MEDLINE/PubMed
spelling pubmed-55742542017-09-08 Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments Ulrich, Nikos Gastmeier, Petra GMS Hyg Infect Control Article Some infection control recommendations distinguish epidemic and endemic levels for infection control. However, it is often difficult to separate long lasting outbreaks from high endemic levels and it remains open, if this distinction is really useful. Aim: To compare infection control measures in endemic and epidemic outbreaks. Methods: The example of vancomycin-resistant Enterococcus faecium outbreaks in haematology or oncology departments was used to analyse differences in infection control measures between outbreaks and high endemic levels. The outbreak database and PubMed, including long lasting outbreaks, were used for this analysis. Two time limits were used for separation: 6 and 12 months. In addition, monoclonal and polyclonal outbreaks were distinguished. Findings: A total of 36 outbreaks were included. 13 outbreaks lasted 6 months or less, 9 outbreaks more than 6 months but at maximum 12 months and 9 more than 12 months. For the remaining outbreaks, no information about their duration was available. Altogether, 11 outbreaks were monoclonal and 20 polyclonal. Considering infection control measures, there were almost no differences between the different groups compared. Patient screening was given up in 37.5% of long lasting outbreaks (>12 months) and hand hygiene not reported in the majority of polyclonal outbreaks (77.8%). Conclusion: Despite many institutions trying to add further infection control measures in case of an outbreak, evidence based infection control measures should be implemented in endemic and epidemic situations. The crucial aspect is probably the degree of implementation and its control in both situations. German Medical Science GMS Publishing House 2017-08-28 /pmc/articles/PMC5574254/ /pubmed/28890862 http://dx.doi.org/10.3205/dgkh000299 Text en Copyright © 2017 Ulrich et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Ulrich, Nikos
Gastmeier, Petra
Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments
title Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments
title_full Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments
title_fullStr Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments
title_full_unstemmed Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments
title_short Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments
title_sort where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? an analysis based on the example of vancomycin-resistant enterococcus faecium in hematology and oncology departments
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574254/
https://www.ncbi.nlm.nih.gov/pubmed/28890862
http://dx.doi.org/10.3205/dgkh000299
work_keys_str_mv AT ulrichnikos whereisthedifferencebetweenanepidemicandahighendemiclevelwithrespecttonosocomialinfectioncontrolmeasuresananalysisbasedontheexampleofvancomycinresistantenterococcusfaeciuminhematologyandoncologydepartments
AT gastmeierpetra whereisthedifferencebetweenanepidemicandahighendemiclevelwithrespecttonosocomialinfectioncontrolmeasuresananalysisbasedontheexampleofvancomycinresistantenterococcusfaeciuminhematologyandoncologydepartments